Factors That Affect Life Expectancy of Patients With Gastric Adenocarcinoma

Helicobacter pylori Test‐and‐Treat Program Can Be Cost‐effective to Prevent Gastric Cancer in Taiwanese Adults: Referred to the Nationwide Reimbursement Database

“…Estimates of direct medical care costs associated with gastric adenocarcinoma were derived from the perspective of a healthcare system and payer, excluding patient time and travel costs. The cohort of patients with gastric adenocarcinoma was thus followed for 14 years to estimate the survival probability through Kaplan–Meier method and then extrapolated to lifetime with a semiparametric method to obtain the lifelong survival probability as previously described , which have been mathematically proved under the assumption of constant excess hazard .…”

“…The ICER of H. pylori test‐and‐treat programs was calculated from the cost of H. pylori test‐and‐treat programs for preventing one gastric cancer minus the average lifetime health expenditure per gastric adenocarcinoma (without test‐and‐treat H. pylori programs currently), divided by the saving of expected years of life lost. The average expected years of life lost for the gastric adenocarcinoma cohort was defined as the mean survival difference between the gastric adenocarcinoma cohort and the age‐ and sex‐matched reference population, as previously described .…”

“…Gastric cancer is still one of the top 10 leading cancers in terms of incidence worldwide. Aside from its poor prognosis, its impact on the financial burden and quality of life is an important public health issue . Measuring the financial burden will be helpful for resource planning and evaluation of the cost‐effectiveness of prevention programs .…”

“…Women and men may have differences in medicine at all levels from genes to whole organisms. Our previous study showed that females with gastric cancer are diagnosed at a younger age and have more expected years of life lost than males with such tumors . Modern gender medicine is characterized by an unbiased comparison between women and men, and it aims at the better treatment of women as well as of men .…”

Consensus on the clinical management, screening‐to‐treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale

“…The National Health Insurance (NHI) program, which covers more than 99% of the population of Taiwan, provides full support for medications used to eradicate H. pylori and endoscopy for pretreatment screening and post‐treatment surveillance. Nonetheless, gastric cancer remains a major cancer in Taiwan . Thus, we developed this consensus statement to improve the clinical management of H. pylori infection in Taiwan and to provide updated treatment strategy recommendations that improve the success of eradication.…”